Barclays PLC Increases Stock Position in MacroGenics, Inc. (NASDAQ:MGNX)
Barclays PLC grew its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 13.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,891 shares of the biopharmaceutical company’s stock after buying an additional 13,138 shares during the period. […]
Barclays PLC grew its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 13.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,891 shares of the biopharmaceutical company’s stock after buying an additional 13,138 shares during the period. […]
